Mylan applies its one global quality standard across its facilities and product line, regardless of market.
At Mylan, whether it’s a medication for millions of people or just a handful, our priorities are to meet or exceed industry standards.
Because there’s nothing generic about our standards, our internal teams conduct reviews of all products from start to finish, no matter where in the world they are made. All of our sites adhere to our one global quality standard. Sixteen of Mylan’s facilities in India, including eight of its API facilities, are approved by the U.S. Food and Drug Administration (FDA). Many of the sites also are approved and regularly inspected by other regulatory authorities, including Australia's Therapeutic Goods Administration, the U.K.’s Medicines and Healthcare Products Regulatory Agency and the World Health Organization.
To us, trust goes beyond our global quality standards. It’s all about caring for the people who will be helped by what we do.
Most of all, quality is the reason we can say to 7 billion people “Our Mylan is Your Mylan”.
"We have one global quality standard, because we know where our priorities are. It all starts and ends with you."
Robert J. Coury, Executive Chairman